By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company ProText Mobility, Inc.

ProText Mobility, Inc. (TXTM)

OTC Currency in USD
$0.00
$0.00
-5.04%
Last Update: 3 Sept 2025, 19:57
$6.42M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.01
52 Week Range

TXTM Stock Price Chart

Explore ProText Mobility, Inc. interactive price chart. Choose custom timeframes to analyze TXTM price movements and trends.

TXTM Company Profile

Discover essential business fundamentals and corporate details for ProText Mobility, Inc. (TXTM) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

19 Aug 2003

Employees

1.00

CEO

Roger Baylis-Duffield

Description

ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Boca Raton, Florida. ProText Mobility, Inc. is a subsidiary of Plandaí Biotechnology, Inc.

TXTM Financial Timeline

Browse a chronological timeline of ProText Mobility, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

TXTM Stock Performance

Access detailed TXTM performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run